US Stock · Smart-money analysis

ABT Abbott Laboratories

QUIET
Price
$99.65
1D
+0.83%
5D
+6.09%
20D
+12.60%
Conviction
66
Buy Score
69
Signal
QUIET
Phase
RUNNING
RVOL
0.8×
RSI
60.6
52w range
$81.97 – $137.49
Sector
Healthcare

ABT (Abbott Laboratories) is a US stock trading at $99.65, +0.83% on the day. mdvin's smart-money engine places it in the RUNNING operator phase, with a GRINDER accumulation style. Current conviction is 66/100 and the Buy Score is 69. The active signal is QUIET. It has ignited 1 time(s) in the last 90 sessions, paying off 33% of the time (typical run +2.8%). Reversal/trap risk is graded LOW. On fundamentals it looks fair value (quality grade B, analyst upside +16.70%).

Fundamentals

P/E
28.0
Fwd P/E
16.5
PEG
1.32
ROE
12.3%
Valuation
FAIR VALUE
Quality
B
Analyst upside
+16.70%
Next earnings
2026-10-14
Live deep-dive → Open chart Full screener

Snapshot updated daily; open the live deep-dive for the latest. Educational only — not investment advice.